Vimarsana
Biggest News Aggregation in the World

Anders Neijber News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anders Neijber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anders Neijber Today - Breaking & Trending Today

Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved It - Vimarsana News

Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved It

Published: September 20, 2023

OSLO, Norway, Sept. 20, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces...

Source: notimerica.com
Related Topics:
Ceophotocure AsaemailJinghe LangRelationsphotocure AsatelLinda WuDan SchneiderpresidentPrnewswire PhotocureDavid MoskowitzviceErik Dahlcfophotocure AsatelAnders NeijberCorporate Communications Norway TelAcademy Member DrChinese National Medical Products AdministrationChinese Eugenics AssociationOslo Stock ExchangeCervical Pathology BranchChinese Academy Of Medical SciencesUnion Medical College HospitalAsieris PharmaceuticalsBladder Cancer CompanyAsieris Meditech Co LtdExpert Committee Of ColposcopyAcademy MemberPeking Union Medical College HospitalChinese AcademyMedical Sciences
Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of - Vimarsana News

Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of

Published: May 2, 2023

OSLO, Norway, May 2, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces...

Source: europapress.es
Related Topics:
United StatesNew ZealandKarl StorzPrnewswire PhotocureDavid MoskowitzviceDan SchneiderpresidentRelationsphotocure AsatelCysview HexvixPhotocure AsaphotocureKarsten ZiegerHexvix CysviewAnders NeijberCeophotocure AsaemailErik Dahlcfophotocure AsatelNorthwestern University ChicagoDepartment Of UrologyAmerican Urological AssociationAmerican Urological Association Annual CongressBladder Cancer CompanyClinical DevelopmentOslo Stock ExchangeAmerican Cancer SocietyGlobal Medical AffairsCorporate Communications Norway TelNordic Registry
Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light Cystoscopy - Vimarsana News

Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light Cystoscopy

Published: May 2, 2023

Press Release - Oslo, Norway, May 2, 2023: Photocure ASA , the Bladder Cancer Company, announces that results from the Nordic Registry demonstrating benefits of Blue Light Cystoscopy were presented... | June 18, 2023

Source: marketscreener.com
Related Topics:
Northwestern UniversityUnited StatesNew ZealandErik DahlKarl StorzKarsten ZiegerAnders NeijberDan SchneiderCysview HexvixHexvix CysviewDavid MoskowitzAmerican Urological Association Annual CongressAmerican Urological AssociationDepartment Of UrologyClinical DevelopmentAmerican Cancer SocietyBladder Cancer CompanyOslo Stock ExchangeGlobal Medical AffairsCorporate CommunicationsPress ReleaseCancer CompanyNordic RegistryBlue Light CystoscopyExperts Treat
Photocure appoints Anders Neijber, MD, PhD as Chief Medical Officer, Global Medical Affairs and Clinical Development - Vimarsana News

Photocure appoints Anders Neijber, MD, PhD as Chief Medical Officer, Global Medical Affairs and Clinical Development

Published: September 1, 2022

OSLO, Norway, Sept. 1, 2022 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Dr. Anders Neijber to the position of Chief Medical Officer

Source: finanznachrichten.de
Related Topics:
Robert Wood Johnson Medical SchoolNew JerseyUnited StatesPrnewswire PhotocureErik DahlAnders NeijberDan SchneiderDavid MoskowitzGlobal Medical AffairsBladder Cancer CompanyDepartment Of Clinical PharmacologyVp Medical AffairsCorporate Communications NorwayClinical DevelopmentOslo Stock ExchangeChief Medical OfficerMedical AffairsAssistant ProfessorClinical PharmacologyChief Executive Officer
Photocure Partner Asieris announces Approval to conduct a Phase III Clinical Trial for Hexvix in China - Vimarsana News

Photocure Partner Asieris announces Approval to conduct a Phase III Clinical Trial for Hexvix in China

Published: February 11, 2022

OSLO, Norway, Feb. 11, 2022 /PRNewswire/ -- Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has obtained the Phase III

Source: finanznachrichten.de
Related Topics:
United StatesNew ZealandYong XuePrnewswire PhotocureErik DahlDan SchneiderDavid MoskowitzCysview HexvixHexvix CysviewAnders NeijberLi HanzhongClinical Development At PhotocureGlobal Medical AffairsBladder Cancer CompanyUnion Medical College HospitalHead Of The Department SurgeryAsieris PharmaceuticalsCorporate Communications NorwayNational Medical Products AdministrationChinese Academy Of Medical SciencesAmerican Cancer SocietyOslo Stock ExchangePeking Union Medical College HospitalChinese AcademyProfessor Li Hanzhong